Medtronic, Inc. announced the international market launch of CareLink(R) Pro 3 Therapy Management Software, the first software program to offer advanced decision support to healthcare professionals managing diabetes. The software analyzes data from a patient’s insulin pump, continuous glucose monitoring (CGM) device, and blood glucose meter to identify the most important patient information in one easy-to-use dashboard. In addition, the software offers therapy considerations that clinicians can use as a starting point to discuss therapy changes with their patients to help improve glucose control.
Medtronic is the global leader in medical technology, alleviating pain, restoring health and extending life for millions of people around the world. With deep roots in the treatment of heart disease, Medtronic now provides a wide range of products and therapies –every four seconds, another life is improved by a Medtronic product or therapy.
MEMS have long been used in biomedical sensing applications around the patient,for monitoring things like blood pressure or activity levels in people or ?ow rates in bedside equipment. But now products based on the major progress in MEMS technology of the last few years are starting to make it through the long Biomedical development process to the market, applying that sensing information to intervene inside the body, in smarter implants and better minimally invasive procedures.
Students can refer this post to start working on their projects. Students can take ideas and start the project
Biomedical electronics research is being driven by the aging “baby-boomer” population and their medical needs. This phenomenon is spurring fast development of new biotechnologies and need for access to innovative means of medical diagnosis and treatment in preventive medicine. Subsequently, the technologies of implants and advanced wireless electronic media will help alleviate rising medical costs in today’s society and extend the average longevity with a quality life in our later years.
Medtronic is the world leader in medical technology providing lifelong solutions for people with chronic disease. We offer products, therapies and services that enhance or extend the lives of millions of people. Each year, 2.5 million patients benefit from Medtronic’s technology, used to treat conditions such as heart disease, neurological disorders, and vascular illnesses.
Medtronic was founded in 1949 by Earl E. Bakken and the late Palmer J. Hermundslie.